瑞士股市周二遭遇普跌行情中，罗氏控股股价下跌1.0%，报收255.00瑞郎。当日瑞士基准股指SMI下跌0.3%，收报11901.32点。
当前股价较今年3月12日创下的52周高点313.80瑞郎尚有58.80瑞郎差距。值得注意的是，当日成交量仅为69.5万股，显著低于50日平均成交量101.2万股。
欧洲时段尾盘交易数据显示，这家医药巨头延续了近期弱势表现，在蓝筹股集体承压的环境下表现尤为疲软。技术指标显示，股价已连续三个交易日运行于关键均线下方，量能萎缩暗示市场参与度降低。
瑞士股市周二遭遇普跌行情中，罗氏控股股价下跌1.0%，报收255.00瑞郎。当日瑞士基准股指SMI下跌0.3%，收报11901.32点。
当前股价较今年3月12日创下的52周高点313.80瑞郎尚有58.80瑞郎差距。值得注意的是，当日成交量仅为69.5万股，显著低于50日平均成交量101.2万股。
欧洲时段尾盘交易数据显示，这家医药巨头延续了近期弱势表现，在蓝筹股集体承压的环境下表现尤为疲软。技术指标显示，股价已连续三个交易日运行于关键均线下方，量能萎缩暗示市场参与度降低。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.